PET imaging of prostate-specific membrane antigen in prostate cancer: current state of the art and future challenges
about
Correlation of PSMA-Targeted 18F-DCFPyL PET/CT Findings With Immunohistochemical and Genomic Data in a Patient With Metastatic Neuroendocrine Prostate Cancer.PSMA-Targeted 18F-DCFPyL PET/CT Imaging of Clear Cell Renal Cell Carcinoma: Results from a Rapid Autopsy.Comparison of hybrid (68)Ga-PSMA-PET/CT and (99m)Tc-DPD-SPECT/CT for the detection of bone metastases in prostate cancer patients: Additional value of morphologic information from low dose CT.Prostate Specific Membrane Antigen Targeted 18F-DCFPyL Positron Emission Tomography/Computerized Tomography for the Preoperative Staging of High Risk Prostate Cancer: Results of a Prospective, Phase II, Single Center Study.Status and trends in the development of clinical diagnostic agents.68Ga-PSMA PET/CT imaging in recurrent prostate cancer: Where are we now?Multimodal Imaging in Focal Therapy Planning and Assessment in Primary Prostate Cancer.Molecular Imaging of Hydrolytic Enzymes Using PET and SPECT.Lymph node imaging in initial staging of prostate cancer: An overview and update.High-intensity Focused Ultrasound (HIFU) as salvage therapy for radio-recurrent prostate cancer: predictors of disease response.What role does stereotactic ablative radiotherapy have in advanced castrate-resistant prostate cancer?Clinical impact of PSMA-based 18F-DCFBC PET/CT imaging in patients with biochemically recurrent prostate cancer after primary local therapy.Molecular imaging of advanced thyroid cancer: iodinated radiotracers and beyond.Defining the clinical utility of PSMA-targeted PET imaging of prostate cancer.Combined model-based and patient-specific dosimetry for 18F-DCFPyL, a PSMA-targeted PET agent.A PSMA-targeted theranostic agent for photodynamic therapy.Kidney cancer: PSMA: a potential therapeutic target in RCC.18F-DCFBC Prostate-Specific Membrane Antigen-Targeted PET/CT Imaging in Localized Prostate Cancer: Correlation With Multiparametric MRI and Histopathology.Best of the 2016 AUA Annual Meeting: Highlights From the 2016 American Urological Association Annual Meeting, May 6-10, 2016, San Diego, CA.Patterns of failure after radical prostatectomy in prostate cancer - implications for radiation therapy planning after 68Ga-PSMA-PET imaging.Salicylic Acid-Based Polymeric Contrast Agents for Molecular Magnetic Resonance Imaging of Prostate Cancer.Nuclear Medicine in Prostate Cancer: A New Era for Radiotracers.Diagnosing small bowel carcinoid tumor in a patient with oligometastatic prostate cancer imaged with PSMA-Targeted [18F]DCFPyL PET/CT: Value of the PSMA-RADS-3D Designation.A Voice From the Past: Rediscovering the Virchow Node With Prostate-specific Membrane Antigen-targeted 18F-DCFPyL Positron Emission Tomography Imaging.Radium and other alpha emitters in prostate cancerKeeping up with the prostate-specific membrane antigens (PSMAs): an introduction to a new class of positron emission tomography (PET) imaging agents
P2860
Q31137270-4CB018D5-2738-4974-B020-617B86392457Q33917916-555D480C-8D75-4822-9F68-42531FD24730Q38639486-7C0B5AFC-F17D-458F-992E-4EADC6E1A36FQ38665724-3B326B94-31DE-47CC-8A1B-50FA92389FB8Q38995734-55FD5B0D-91A5-40C4-AC94-988EFE3A1069Q39276928-08323E32-AD3E-4AEC-BD7B-372EDA9469A3Q39438297-93EF3F58-2234-4C97-9FD7-264CD8FFCCF1Q41862863-715ED271-1447-44DC-8E7B-B155350F75CDQ47157403-D368587E-D27E-4DC5-8B69-D37FD193A014Q47277749-E5CD734E-58D0-415F-84D9-A1D3BC2F5B9BQ47904167-8BA538C5-58B0-4101-8250-72198E68E52AQ48089415-FA3C14BA-99DA-4B8F-A22B-F9D5BAF0A380Q48098904-D1ABBF02-DDD2-4FBB-AA10-653FBE4413CAQ48108274-2573922D-628A-4BC4-A487-DE18558E0338Q49827187-0B70F87B-BCD7-4AA7-9151-7995F2B124BDQ49953699-526059EA-6462-4C31-855A-8B12C9CFEC69Q50078779-97352092-F33B-47BD-8BBC-54E1392CB3A2Q50430295-73FC78C9-C21A-4E5E-8E7B-19C1DF2E4F2DQ51324448-0ED54224-4A4E-434E-AA65-EACBC6AB9CC7Q51840218-89406C9B-D4D7-4C5D-87F2-B7B443DCE3C5Q52672556-3AB22274-A74E-43FF-9044-3D233B59AF9DQ55261098-F5207D23-8D77-406E-BE1E-93A37D65D196Q55401970-F4513254-EC55-4F1F-B330-6896009782E8Q55432719-FC592850-8AC2-42DB-845B-A77357B2CF3EQ57112384-E8AAF9FA-027D-4776-AC1E-47FC98A2C7F8Q59130960-72349A35-7A67-418A-B8CB-75B9362B04B3
P2860
PET imaging of prostate-specific membrane antigen in prostate cancer: current state of the art and future challenges
description
2016 nî lūn-bûn
@nan
2016 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
PET imaging of prostate-specif ...... the art and future challenges
@ast
PET imaging of prostate-specif ...... the art and future challenges
@en
PET imaging of prostate-specif ...... the art and future challenges
@nl
type
label
PET imaging of prostate-specif ...... the art and future challenges
@ast
PET imaging of prostate-specif ...... the art and future challenges
@en
PET imaging of prostate-specif ...... the art and future challenges
@nl
prefLabel
PET imaging of prostate-specif ...... the art and future challenges
@ast
PET imaging of prostate-specif ...... the art and future challenges
@en
PET imaging of prostate-specif ...... the art and future challenges
@nl
P2093
P2860
P356
P1476
PET imaging of prostate-specif ...... the art and future challenges
@en
P2093
K J Pienta
M G Pomper
P2860
P2888
P304
P356
10.1038/PCAN.2016.13
P407
P577
2016-05-03T00:00:00Z